The synergistic and antagonistic effects of cytotoxic and biological agents on the in vitro antitumour effects of suramin

This publication has 25 references indexed in Scilit:

• Antagonism by Suramin of the Growth-Inhibitory Effect of Hydroxytamoxifen and Doxorubicin in Human MCF-7 Breast Cancer Cells
  JNCI Journal of the National Cancer Institute, 1992
• The effect of schedule, protein binding and growth factors on the activity of suramin
  International Journal of Cancer, 1992
• Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing
  European Journal of Cancer and Clinical Oncology, 1991
• Suramin, a novel antitumor compound
  The Journal of Steroid Biochemistry and Molecular Biology, 1990
• Suramin Blockade of Insulinlike Growth Factor I-Stimulated Proliferation of Human Osteosarcoma Cells
  JNCI Journal of the National Cancer Institute, 1990
• Synergistic Activity of Suramin With Tumor Necrosis Factor and Doxorubicin on Human Prostate Cancer Cell Lines
  JNCI Journal of the National Cancer Institute, 1990
• New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
  JNCI Journal of the National Cancer Institute, 1990
• Suramin: A new therapeutic concept
  European Journal of Cancer and Clinical Oncology, 1990
• Observations on the suramin-mediated inhibition of cellular and viral DNA polymerases
  Biochemical and Biophysical Research Communications, 1985
• Suramin enhancement of the chemotherapeutic actions of cyclophosphamide or adriamycin of intramuscularly-implanted Ehrlich carcinoma
  Cancer Letters, 1979